The #PEACE3 trial seems to be paving the way for innovative treatment options in #mCRPC with radium-223 and enzalutamide. Radiographic progression-free survival is a crucial aspect for patient outcomes, but I'm curious about the safety profile these results suggest. How does this trial's design compare to previous studies in this space? For those interested in a deeper dive into such biomedical topics, I recommendIt’s a fantastic platform to explore any biomedical question and generate comprehensive reviews. #Medicine
#PEACE3 #mCRPC